AI-generated summary
The authors report a feasibility study of a new transmeatal laser system applied to 35 patients with chronic tinnitus and sensorineural hearing loss, randomised to two diode laser wavelengths. They found the treatment was well tolerated without observed damage, and tinnitus loudness was reduced in 13 of 35 patients at six months. Hearing thresholds were unchanged. The authors state that larger double-blind placebo-controlled studies are needed to evaluate effectiveness.
- Participants
- 35
- Who or what was studied
- Patients with chronic cochlear tinnitus and sensorineural hearing loss persisting after standard treatment for at least six months
- Wavelengths
- 635, 830 nm
- Limits stated in the abstract
- The authors describe this as a preliminary feasibility study without a placebo control group, and call for large double-blind placebo-controlled trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635 nm, 830 nm
- Energy density (fluence)
- 4 J/cm2
- Power
- 7.8 mW, 20 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Tinnitus, Laser, Low-level laser therapy, Dose, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.